Logo image of TMDX

TRANSMEDICS GROUP INC (TMDX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TMDX - US89377M1099 - Common Stock

135.3 USD
-2.79 (-2.02%)
Last: 1/23/2026, 8:00:02 PM
135 USD
-0.3 (-0.22%)
After Hours: 1/23/2026, 8:00:02 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to TMDX. TMDX was compared to 184 industry peers in the Health Care Equipment & Supplies industry. TMDX has an excellent financial health rating, but there are some minor concerns on its profitability. TMDX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make TMDX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year TMDX was profitable.
  • TMDX had a positive operating cash flow in the past year.
  • TMDX had negative earnings in 4 of the past 5 years.
  • In the past 5 years TMDX reported 4 times negative operating cash flow.
TMDX Yearly Net Income VS EBIT VS OCF VS FCFTMDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

  • TMDX's Return On Assets of 9.70% is amongst the best of the industry. TMDX outperforms 93.55% of its industry peers.
  • With an excellent Return On Equity value of 25.84%, TMDX belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
  • TMDX has a better Return On Invested Capital (8.75%) than 88.17% of its industry peers.
Industry RankSector Rank
ROA 9.7%
ROE 25.84%
ROIC 8.75%
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
TMDX Yearly ROA, ROE, ROICTMDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300 400

1.3 Margins

  • TMDX has a better Profit Margin (16.20%) than 93.01% of its industry peers.
  • The Operating Margin of TMDX (16.94%) is better than 87.63% of its industry peers.
  • TMDX's Gross Margin of 60.28% is fine compared to the rest of the industry. TMDX outperforms 61.83% of its industry peers.
  • In the last couple of years the Gross Margin of TMDX has remained more or less at the same level.
Industry RankSector Rank
OM 16.94%
PM (TTM) 16.2%
GM 60.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
TMDX Yearly Profit, Operating, Gross MarginsTMDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

7

2. Health

2.1 Basic Checks

  • TMDX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for TMDX has been increased compared to 1 year ago.
  • The number of shares outstanding for TMDX has been increased compared to 5 years ago.
  • TMDX has a better debt/assets ratio than last year.
TMDX Yearly Shares OutstandingTMDX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
TMDX Yearly Total Debt VS Total AssetsTMDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 5.74 indicates that TMDX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of TMDX (5.74) is better than 79.03% of its industry peers.
  • The Debt to FCF ratio of TMDX is 4.24, which is a neutral value as it means it would take TMDX, 4.24 years of fcf income to pay off all of its debts.
  • TMDX's Debt to FCF ratio of 4.24 is amongst the best of the industry. TMDX outperforms 80.11% of its industry peers.
  • A Debt/Equity ratio of 1.43 is on the high side and indicates that TMDX has dependencies on debt financing.
  • TMDX's Debt to Equity ratio of 1.43 is on the low side compared to the rest of the industry. TMDX is outperformed by 78.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 4.24
Altman-Z 5.74
ROIC/WACC0.91
WACC9.63%
TMDX Yearly LT Debt VS Equity VS FCFTMDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • TMDX has a Current Ratio of 7.69. This indicates that TMDX is financially healthy and has no problem in meeting its short term obligations.
  • TMDX's Current ratio of 7.69 is amongst the best of the industry. TMDX outperforms 88.71% of its industry peers.
  • A Quick Ratio of 7.13 indicates that TMDX has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 7.13, TMDX belongs to the top of the industry, outperforming 89.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.69
Quick Ratio 7.13
TMDX Yearly Current Assets VS Current LiabilitesTMDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

8

3. Growth

3.1 Past

  • TMDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 162.77%, which is quite impressive.
  • The Revenue has grown by 41.20% in the past year. This is a very strong growth!
  • Measured over the past years, TMDX shows a very strong growth in Revenue. The Revenue has been growing by 79.64% on average per year.
EPS 1Y (TTM)162.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%450%
Revenue 1Y (TTM)41.2%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%32.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.25% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 21.23% on average over the next years. This is a very strong growth
EPS Next Y163.58%
EPS Next 2Y71.04%
EPS Next 3Y53.35%
EPS Next 5Y33.25%
Revenue Next Year39.6%
Revenue Next 2Y29.73%
Revenue Next 3Y25.56%
Revenue Next 5Y21.23%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TMDX Yearly Revenue VS EstimatesTMDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
TMDX Yearly EPS VS EstimatesTMDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 54.78, the valuation of TMDX can be described as expensive.
  • Based on the Price/Earnings ratio, TMDX is valued a bit cheaper than the industry average as 69.35% of the companies are valued more expensively.
  • TMDX is valuated expensively when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 45.79, TMDX can be considered very expensive at the moment.
  • 69.89% of the companies in the same industry are more expensive than TMDX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of TMDX to the average of the S&P500 Index (25.98), we can say TMDX is valued expensively.
Industry RankSector Rank
PE 54.78
Fwd PE 45.79
TMDX Price Earnings VS Forward Price EarningsTMDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • TMDX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 68.28% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, TMDX is valued a bit cheaper than 76.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 38.34
EV/EBITDA 38.37
TMDX Per share dataTMDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • TMDX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TMDX's earnings are expected to grow with 53.35% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y71.04%
EPS Next 3Y53.35%

0

5. Dividend

5.1 Amount

  • No dividends for TMDX!.
Industry RankSector Rank
Dividend Yield 0%

TRANSMEDICS GROUP INC / TMDX FAQ

Can you provide the ChartMill fundamental rating for TRANSMEDICS GROUP INC?

ChartMill assigns a fundamental rating of 6 / 10 to TMDX.


Can you provide the valuation status for TRANSMEDICS GROUP INC?

ChartMill assigns a valuation rating of 5 / 10 to TRANSMEDICS GROUP INC (TMDX). This can be considered as Fairly Valued.


How profitable is TRANSMEDICS GROUP INC (TMDX) stock?

TRANSMEDICS GROUP INC (TMDX) has a profitability rating of 5 / 10.


How financially healthy is TRANSMEDICS GROUP INC?

The financial health rating of TRANSMEDICS GROUP INC (TMDX) is 7 / 10.